HIGHLIGHTS
- who: Zhuandi Liu from the (UNIVERSITY) have published the article: Current insight into the regulation of PD-L1 in cancer, in the Journal: (JOURNAL)
- what: In this review the authors focus on the of in cells and summarize the underlying mechanisms.
- future: Preclinical and clinical studies will be needed to advance the understanding of tumor immune evasion mechanisms and the search for optimal combination therapies.
SUMMARY
T-lymphocyte associated protein 4 (CTLA4), hepatitis A virus cellular receptor 2 (HAVCR2, TIM3), and T_cell immunoreceptor with Ig and ITIM domains (TIGIT . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.